spravato depression - Search News

Spravato, depression

Nose spray to treat depression? FDA approves first-of-its-kind medicine

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

PopSugar · 3d

Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Monthly Prescribing Reference · 2d

Spravato Approved as Monotherapy for Treatment-Resistant Depression

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial.

BioSpace4d

J&J’s Spravato Makes Headway in Tough Depression Space With Monotherapy Approval

Esketamine, the active ingredient in Spravato, is a non-selective, non-competitive antagonist of the NMDA receptor, a known ...

mic5d

A Nasal Spray For Depression? FDA Gives Its Approval

This innovative treatment is poised to change the landscape of depression management ... making effective treatments crucial. Spravato is derived from ketamine, a drug that has gained attention ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Spravato, depression

Trending now